Zobrazeno 1 - 5
of 5
pro vyhledávání: '"F. Oğuz Önder"'
Autor:
Cihan Yurdaydin, Aysun Çalişkan, Xheni Deda, Fatih Karakaya, F. Oğuz Önder, Senem Ceren Karatayli, Onur Keskin, Ramazan Idilman, A. Mithat Bozdayi, Hakan Bozkaya, Çağdaş Kalkan, Ersin Karatayli, Gökhan Kabaçam
Publikováno v:
The Journal of infectious diseases. 217(8)
Background Interferon is the only treatment option in chronic delta hepatitis (CDH). A CDH database (333 patients, 161 with interferon treatment history) was analyzed for effects of treatment duration on virologic response and clinical outcomes. Meth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d69d26700d16390ef42152f274bbfd8c
https://pubmed.ncbi.nlm.nih.gov/29425322
https://pubmed.ncbi.nlm.nih.gov/29425322
Autor:
Hakan Bozkaya, Berna Terzioglu, Akif Tan, M. Zafer Gören, Cihan Yurdaydin, Turgay Celik, A. Mithat Bozdayi, Kubilay Cinar, Ozden Uzunalimoglu, F. Oğuz Önder, Hakan Gurdal
Publikováno v:
Hepatology. 41:731-737
Fatigue associated with cholestasis may impair health-related quality of life. The pathogenesis of this symptom is largely unknown, but it has been suggested that central serotoninergic neurotransmission may be implicated and that serotonin 1A recept
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b981fa73a8201d96ab86fc5f555b79c1
https://doi.org/10.1002/hep.20617
https://doi.org/10.1002/hep.20617
Autor:
A. Mithat Bozdayi, Berna Savaş, Cihan Yurdaydin, Ersin Karatayli, Mustafa Yakut, F. Oğuz Önder, Gökhan Kabaçam, Senem Ceren Karatayli, Gülseren Seven, Ramazan Idilman
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 55(5)
Background. Hepatitis D virus (HDV) requires hepatitis B surface antigen (HBsAg) to propagate infection and cause disease. Entecavir is a nucleoside analog with potent antiviral efficacy, and in the woodchuck animal model it also decreased hepatitis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c497694a6e78b5dd4043f1fe2279bf86
https://pubmed.ncbi.nlm.nih.gov/22573857
https://pubmed.ncbi.nlm.nih.gov/22573857
Autor:
Sabahattin Kaymakoglu, Mehmet Bektas, Emel Ahishali, Binnur Pinarbasi, Hakan Bozkaya, F. Oğuz Önder, Cihan Yurdaydin, Yilmaz Cakaloglu, A. Mithat Bozdayi, Selim Badur, Atilla Ökten, Ramazan Idilman, Kubilay Cinar, Selim Karayalcin
Publikováno v:
Journal of viral hepatitis. 16(4)
SUMMARY. The aims of the study were to investigate the efficacy of rescue therapy with lamivudine (LAM) and adefovir (ADV) combination for 6 months followed by ADV monotherapy in lamivudine-resistant chronic hepatitis B (LAM-R CHB) patients, and to a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1ea9153e5019142da37f170fff89ad6
https://pubmed.ncbi.nlm.nih.gov/19222742
https://pubmed.ncbi.nlm.nih.gov/19222742
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.